Oberweis Asset Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Oberweis Asset Management’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-233,079	Closed	-$6.53M	–	151
2016 Q3	$6.53M	Sell	233,079 -4,436	-2%	-$149K	1.88%	14
2016 Q2	$8.31M	Sell	237,515 -16,880	-7%	-$531K	2.47%	9
2016 Q1	$6.97M	Sell	254,395 -95,530	-27%	-$2.81M	2.01%	12
2015 Q4	$12M	Buy	349,925 +73,466	+27%	+$2.29M	3.36%	4
2015 Q3	$7.94M	Buy	276,459 +20,300	+8%	+$868K	2.31%	15
2015 Q2	$11.5M	Sell	256,159 -63,717	-20%	-$2.4M	3.03%	4
2015 Q1	$11.1M	Sell	319,876 -11,130	-3%	-$303K	3.11%	5
2014 Q4	$9.06M	Buy	+331,006	New	+$8.03M	2.71%	8

Other funds holding DPLO

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Oberweis Asset Management's DPLO Position: Q4 2016 in Review

Oberweis Asset Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2016, closing a stake of 233,079 shares — an estimated $6.53M sold.

Oberweis Asset Management first reported a position in DPLO in Q4 2014 and held it in 8 quarters. The position peaked at $12M in Q4 2015. 174 funds tracked by Wall St. Rank hold DPLO as of Q4 2016.

Oberweis Asset Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2016 after selling out during the quarter.
Oberweis Asset Management sold 233,079 DIPLOMAT PHARMACY, INC. shares in Q4 2016, an estimated $6.53M.
Oberweis Asset Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 8 quarters.
Oberweis Asset Management's DIPLOMAT PHARMACY, INC. position peaked at $12M in Q4 2015.
174 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2016.

Based on Oberweis Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.